Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ.
Li X, Hernandez I, Koyuncu S, Kis B, Häggblad M, Lidemalm L, Abbas AA, Bendegúz S, Göblös A, Brautigam L, Lucas JJ, Carreras-Puigvert J, Hühn D, Pircs K, Vilchez D, Fernandez-Capetillo O. Li X, et al. Among authors: kis b. EBioMedicine. 2024 May;103:105124. doi: 10.1016/j.ebiom.2024.105124. Epub 2024 May 2. EBioMedicine. 2024. PMID: 38701619 Free PMC article.
Exploring the Relationship between Adherence to Therapy, Treatment Acceptability, and Clinical Outcomes in Adults with Attention-Deficit/Hyperactivity Disorder: Results from the COMPAS Multicenter Randomized Controlled Trial.
López-Pinar C, Rosen H, Selaskowski B, Staerk C, Jans T, Retz W, Retz-Junginger P, Roesler M, Sobanski E, Huss M, Matthies S, Tebartz van Elst L, Berger M, Jacob C, Kis B, Colla M, Alm B, Abdel-Hamid M, Martínez-Sanchís S, Carbonell-Vayá E, Lux S, Philipsen A. López-Pinar C, et al. Among authors: kis b. Psychother Psychosom. 2024;93(1):46-64. doi: 10.1159/000532043. Epub 2023 Dec 22. Psychother Psychosom. 2024. PMID: 38142690 Clinical Trial.
Exploring the efficacy of dialectical behaviour therapy and methylphenidate on emotional comorbid symptoms in adults with attention Deficit/Hyperactivity disorder: Results of the COMPAS multicentre randomised controlled trial.
López-Pinar C, Selaskowski B, Braun N, Fornés-Ferrer V, Euscher R, Matthies S, Jans T, van Elst LT, Jacob C, Huss M, Sobanski E, Retz W, Roesler M, Retz-Junginger P, Alm B, Kis B, Abdel-Hamid M, Colla M, Berger M, Lux S, Philipsen A. López-Pinar C, et al. Among authors: kis b. Psychiatry Res. 2023 Dec;330:115610. doi: 10.1016/j.psychres.2023.115610. Epub 2023 Nov 18. Psychiatry Res. 2023. PMID: 37992514 Clinical Trial.
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators. Reif A, et al. N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145. N Engl J Med. 2023. PMID: 37792613 Clinical Trial.
Fountain of youth-Targeting autophagy in aging.
Danics L, Abbas AA, Kis B, Pircs K. Danics L, et al. Among authors: kis b. Front Aging Neurosci. 2023 Mar 29;15:1125739. doi: 10.3389/fnagi.2023.1125739. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37065462 Free PMC article. Review.
Phytochemical Characterization and Biological Evaluation of Origanum vulgare L. Essential Oil Formulated as Polymeric Micelles Drug Delivery Systems.
Bora L, Burkard T, Juan MHS, Radeke HH, Muț AM, Vlaia LL, Magyari-Pavel IZ, Diaconeasa Z, Socaci S, Borcan F, Kis B, Muntean D, Dehelean CA, Danciu C. Bora L, et al. Among authors: kis b. Pharmaceutics. 2022 Nov 8;14(11):2413. doi: 10.3390/pharmaceutics14112413. Pharmaceutics. 2022. PMID: 36365231 Free PMC article.
198 results